Biotech Values

[jbog]

genisi,

Biogen has enrolled a small ph II trial adding BG12 to the Beta Interferons (IFNß Copaxone, rebif etc.) or Glatiramer Acetate (GA).

You can bet your bottom dollar that eventually Biogen will want head to head trials against Rebif and Copaxone while they try to protect their avonex franchise.